This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Two articles from investigators at the Mayo Clinic published in this issue1,2 address clinical issues in the diagnosis of disorders in the spectrum of frontotemporal lobar degenerations (FTLD) from the perspective of the underlying pathologies. The FTLDs represent a complex group of disorders with muddled and confusing nomenclature. Attempts to clarify the relationships between clinical and neuroimaging features and the underlying pathologies may improve phenotypic characterizations, which in turn may lead to better understanding of salient pathogenic mechanisms and ultimately aid the development of specific therapies and management strategies. These two articles take as their starting point autopsy-confirmed cases of FTLD, corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP) that had been entered into the Mayo Clinic medical records database from 1970 through 2004 and then extensively re-examined with state-of-the-art immunohistochemistry.
The study of Josephs et al.1 sought to match clinical diagnosis, based on early features conforming to published consensus guidelines, with a final pathologic diagnosis. The approach is retrospective and grants to pathology its traditional status as the gold standard. The medical record review yielded an autopsy series of 127 cases (57 FTLD, 49 PSP, and 21 CBD). The pathology was re-assessed in isolation from clinical and diagnostic data using the most current methods and diagnostic guidelines. Simultaneously the clinical records were screened in isolation from pathologic data for diagnostic features that might discriminate among disorders of the FTLD spectrum.
Pathologically two broad categories emerged, cases with tau pathology (classified as Pick's disease, CBD, PSP, multisystem tauopathy, and frontotemporal dementia …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.